Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Anetumab ravtansine
Trade Name
Synonyms BAY94-9343|BAY 94-9343
Drug Descriptions

Anetumab ravtansine (BAY94-9343) is a monoclonal antibody against mesothelin (MSLN) in conjugation with maytansinoid DM4, which delivers maytansinoid DM4 to tumor cells over expressing mesothelin, resulting in tumor cell death (PMID: 24714131, PMID: 32815024, PMID: 32213105).

DrugClasses MSLN Antibody 12
CAS Registry Number 1375258-01-7
NCIT ID C98293

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Anetumab ravtansine Anetumab ravtansine 0 5
Anetumab ravtansine + Atezolizumab Anetumab ravtansine Atezolizumab 0 1
Anetumab ravtansine + Bevacizumab Anetumab ravtansine Bevacizumab 0 1
Anetumab ravtansine + Cisplatin Anetumab ravtansine Cisplatin 0 1
Anetumab ravtansine + Cisplatin + Pemetrexed Disodium Anetumab ravtansine Cisplatin Pemetrexed Disodium 0 1
Anetumab ravtansine + Gemcitabine Anetumab ravtansine Gemcitabine 0 1
Anetumab ravtansine + Gemcitabine + Nivolumab Anetumab ravtansine Gemcitabine Nivolumab 0 1
Anetumab ravtansine + Ipilimumab + Nivolumab Anetumab ravtansine Ipilimumab Nivolumab 0 1
Anetumab ravtansine + Itraconazole Anetumab ravtansine Itraconazole 0 1
Anetumab ravtansine + Nivolumab Anetumab ravtansine Nivolumab 0 1
Anetumab ravtansine + Pembrolizumab Anetumab ravtansine Pembrolizumab 0 1


Additional content available in CKB BOOST